Health Care & Life Sciences » Pharmaceuticals | Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp. | Key People and Executives

Seth Lederman
Chairman, President & Chief Executive Officer
Adeoye Y. Olukotun
Director
David L. Grange
Independent Director
Margaret Smith Bell
Independent Director
Donald W. Landry
Independent Director
John B. Rhodes
Lead Independent Director
Patrick P. Grace
Independent Director
Charles E. Mather
Independent Director
Seth Lederman
Chairman, President & Chief Executive Officer
Jessica Edgar Morris
Chief Operating Officer
Bradley Saenger
Chief Financial Officer & Treasurer
Gregory M. Sullivan
Secretary & Chief Medical Officer
Mark T. Edgar
Senior Vice President-Product Development
Ronald R. Notvest
Senior VP-Commercial Planning & Development
Adeoye Y. Olukotun
Director
David L. Grange
Independent Director
Margaret Smith Bell
Independent Director
Donald W. Landry
Independent Director
John B. Rhodes
Lead Independent Director
Patrick P. Grace
Independent Director
Charles E. Mather
Independent Director

About Tonix Pharmaceuticals Holding

View Profile
Address
509 Madison Avenue
New York New York 10022
United States
Employees -
Website http://www.tonixpharma.com
Updated 07/08/2019
Tonix Pharmaceuticals Holding Corp. operates as a clinical-stage pharmaceutical company, which engages in the development of pharmaceutical products for public health challenges. It focuses on delivering an efficacious, and safe long-term treatment for posttraumatic stress disorder. It offers TNX-102 SL, TNX-601, TNX-801, TNX-301, and TNX-701.